Literature DB >> 18801353

Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis.

Tamara Djurić1, Maja Zivković, Djordje Radak, Djole Jekić, Sandra Radak, Ljiljana Stojković, Ranko Raicević, Aleksandra Stanković, Dragan Alavantić.   

Abstract

OBJECTIVES: Stromelysin-1 (MMP-3) as a key member of metalloproteinase family could have an important role in atherogenesis. The 5A/6A polymorphism in the promoter of MMP-3 gene affects the level of MMP-3 gene expression. We assessed whether the MMP-3 promoter low- and high-activity genotypes are related to susceptibility for carotid atherosclerosis (CA) in Serbian population. DESIGN AND METHODS: The study group of case-control design consisted of 515 participants. The 265 patients with ultrasonographic evidence of carotid plaque presence were recruited for the study. The 5A/6A polymorphism was typed by RFLP-PCR.
RESULTS: There was significantly higher prevalence of genotypes containing 6A allele in the patients with CA compared to controls (p<0.05). The model of inheritance with the dominant effect of 6A allele gave elevated and significant OR for carotid atherosclerosis (adjusted OR 2.35, CI=1.0-5.5, p=0.048).
CONCLUSIONS: Subjects carrying genotypes with 6A allele had significantly higher susceptibility to carotid atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801353     DOI: 10.1016/j.clinbiochem.2008.08.081

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis.

Authors:  Dan Wen; Xin Du; Shao-Ping Nie; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

2.  Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction?

Authors:  Rasa Liutkevičienė; Diana Žaliaduonytė-Pekšienė; Dalia Žaliūnienė; Olivija Gustienė; Vytautas Jašinskas; Vaiva Lesauskaitė; Abdonas Tamošiūnas; Remigijus Žaliūnas
Journal:  Medicina (Kaunas)       Date:  2012       Impact factor: 2.430

Review 3.  Molecular genetics of atherosclerosis.

Authors:  Himadri Roy; Shalini Bhardwaj; Seppo Yla-Herttuala
Journal:  Hum Genet       Date:  2009-03-20       Impact factor: 4.132

4.  Hemodialysis removes uremic toxins that alter the biological actions of endothelial cells.

Authors:  Kalliopi Zafeiropoulou; Theodora Bita; Apostolos Polykratis; Stella Karabina; John Vlachojannis; Panagiotis Katsoris
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

5.  The associations between red cell distribution width and plasma proteins in a general population.

Authors:  Jingxue Pan; Yan Borné; Marju Orho-Melander; Jan Nilsson; Olle Melander; Gunnar Engström
Journal:  Clin Proteomics       Date:  2021-03-30       Impact factor: 3.988

6.  Association of MMP1 and MMP3 haplotypes with myocardial infarction and echocardiographic parameters of the left ventricle.

Authors:  Tamara Djuric; Jovana Kuveljic; Ana Djordjevic; Milica Dekleva; Goran Stankovic; Aleksandra Stankovic; Maja Zivkovic
Journal:  Mol Genet Genomic Med       Date:  2022-08-01       Impact factor: 2.473

7.  The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse.

Authors:  Paweł Skorupski; Katarzyna Jankiewicz; Paweł Miotła; Małgorzata Marczak; Beata Kulik-Rechberger; Tomasz Rechberger
Journal:  Int Urogynecol J       Date:  2012-10-30       Impact factor: 2.894

8.  Effect of the +781C/T polymorphism in the interleukin-8 gene on atherosclerotic cerebral infarction, and its interaction with smoking and drinking.

Authors:  Shijian Luo; Feng Wang; Zhendong Li; Jinfeng Deng
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

9.  Association of the matrix metalloproteinase-3 polymorphisms rs679620 and rs3025058 with ischemic stroke risk: a meta-analysis.

Authors:  Qi-Wei Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-01-31       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.